APOA5 plays an important role in the pathophysiology of insulin resistance-related hypertriglyceridemia; obese human participants had lower plasma APOA5 levels, which were inversely correlated with TGs, body mass index and homeostasis model assessment of insulin resistance (HOMA-IR) [74]. This evidence concerns the gene APOA5 and Insulin resistance.